Caxton Associates LLP Innoviva, Inc. Put Options Transaction History
Caxton Associates LLP
- $2.87 Trillion
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding INVA
# of Institutions
256Shares Held
75MCall Options Held
2.3KPut Options Held
2.4K-
Black Rock Inc. New York, NY9.63MShares$177 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.3MShares$115 Million0.0% of portfolio
-
Putnam Investments LLC Boston, MA6.27MShares$115 Million0.14% of portfolio
-
Dimensional Fund Advisors LP Austin, TX4.66MShares$85.4 Million0.02% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny4.56MShares$83.5 Million0.13% of portfolio
About Innoviva, Inc.
- Ticker INVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 69,706,000
- Market Cap $1.28B
- Description
- Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...